News Novo Nordisk staff cull swells to 1,300 Novo Nordisk has raised the number of staff it will shed this year in order to invest more in developing new drugs and supporting its most important products.
News Ray's upscaled Series B, and other biofinancings This week's crop of private financings includes nine-figure rounds for Ray Therapeutics and Tortugas, with Serif and Alloy also in on the action.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.